3 most recent filings and news items mentioning HSCS. Updated every 60 seconds.
M&AJul 29, 2026Neutral
HeartSciences announced the filing of a preliminary proxy statement for a business combination with Fortitude Mining Holdings. The company also reported that the MyoVista wavECG device was submitted to the FDA while fiscal 2026 financial results were disclosed.
View filing at SEC.gov →
M&AJul 23, 2026Neutral
HeartSciences filed its fiscal year 2026 Form 10-K and intends to file a preliminary proxy statement shortly regarding a proposed business combination with Fortitude Mining. The company noted this represents a significant opportunity for shareholders.
View filing at SEC.gov →
LeadershipJun 26, 2026Neutral
HeartSciences and Andrew Simpson amended their employment agreement to modify the definition of constructive termination, specifically linking it to the Merger Agreement. This update clarifies severance claims in the event of a potential business combination.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.